Table 7.

Median Percent Changes From Baseline in Selected Lipid Parameters at Month 36^a

	Bazedoxifene		Raloxifene	Placebo
Parameter	20 mg	40 mg	60 mg
Total cholesterol
No. of pairs	1220	1201	1225	1248
Median percent change	-3.8b,c,d	-3.5b,c,d	-5.0b,c	0.3
LDL cholesterol
No. of pairs	1220	1201	1223	1247
Median percent change	-5.4b,c,d	-6.6b,c,d	-8.5b,c	1.6b
HDL cholesterol
No. of pairs	1216	1196	1219	1246
Median percent change	5.1b,c	5.9b,c	5.0b,c	2.5b
LDL/HDL cholesterol
No. of pairs	1213	1191	1215	1244
Median percent change	-10.5b,c,d	-12.6b,c	-12.4b,c	-0.6
Triglycerides
No. of pairs	1220	1201	1225	1248
Median percent change	8.5b	13.6b	12.2b	12.1b

LDL, low-density lipoprotein; HDL, high-density lipoprotein.

^aIncludes subjects in the intent-to-treat population (n = 6,847) with an assessment at baseline and at Month 36.

^bP < 0.001 vs baseline; t test.

^cP < 0.001 vs placebo; t test.

^dP < 0.01 vs raloxifene 60 mg; t test.